WallStreetZenWallStreetZen

NASDAQ: KRON
Kronos Bio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their KRON stock forecasts and price targets.

Forecast return on equity

Is KRON forecast to generate an efficient return?

Company
N/A
Industry
83.55%
Market
67.39%

Forecast return on assets

Is KRON forecast to generate an efficient return on assets?

Company
N/A
Industry
22.55%

KRON earnings per share forecast

What is KRON's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$1.26

KRON revenue forecast

What is KRON's revenue in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
$4.0M-56.48%

KRON vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KRON$0.89N/AN/A
DTIL$4.90$47.00+859.18%Buy
PRLD$0.96$4.50+368.75%Buy
FBIO$1.85$16.00+764.86%Strong Buy
HOWL$1.22$8.33+583.03%Buy
View Top Biotech Stocks

Kronos Bio Stock Forecast FAQ

What is KRON's earnings growth forecast for 2025-2025?

(NASDAQ: KRON) Kronos Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.43%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.71%.

Kronos Bio's earnings in 2025 is -$64,485,000.

In 2025, KRON is forecast to generate -$76,821,210 in earnings, with the lowest earnings forecast at -$76,821,210 and the highest earnings forecast at -$76,821,210.

If you're new to stock investing, here's how to buy Kronos Bio stock.

What is KRON's revenue growth forecast for 2025-2025?

(NASDAQ: KRON) Kronos Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 130.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.85%.

Kronos Bio's revenue in 2025 is $9,192,000.

In 2025, KRON is forecast to generate $243,876,856 in revenue, with the lowest revenue forecast at $243,876,856 and the highest revenue forecast at $243,876,856.

What is KRON's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: KRON) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 22.55%.

What is KRON's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: KRON) Kronos Bio's current Earnings Per Share (EPS) is -$1.07. In 2025, KRON's EPS is forecast to hit -$1.26 (min: -$1.26, max: -$1.26).

What is KRON's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: KRON) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.